Kodu・Aktsiate loetelu・Champions Oncology Inc

C
Champions Oncology Inc

Avatud

SektorTervishoid

5.37 0.19

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5.26

Max

5.55

Põhinäitajad
By Trading Economics
Sissetulek	-389K -667K
Müük	1.5M 17M
P/E Sektori keskmine	35.118 64.641
Aktsiakasum	-0.05
Kasumimarginaal	-4.028
Töötajad	213
EBITDA	-626K -522K

Dividendid
By Acuity
Järgmine tulemuste avaldamine	11. sept 2026

Turustatistika
By TradingEconomics
Turukapital	-555K 84M
Eelmine avamishind	5.18
Eelmine sulgemishind	5.37

Uudiste sentiment

By Acuity

15%

85%

25 / 340 Pingereas Healthcare

Champions Oncology Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. aug 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

31. juuli 2026, 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

30. juuli 2026, 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

29. juuli 2026, 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

28. juuli 2026, 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

27. juuli 2026, 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

24. juuli 2026, 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22. juuli 2026, 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Võrdlus sarnastega

Hinnamuutus

Champions Oncology Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Champions Oncology Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

25 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.